SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

27 May 2022 Evaluate
Net sales declined -18.86%  to  Rs. 90.28 million from Rs. 111.27 millions.The Net Loss for the quarter ended March 2022 is Rs. -16.03 millions as compared to Net Loss of Rs. -7.48 millions of corresponding quarter ended March 2021Operating profit Margin for the quarter ended March 2022 slipped to -9.45% as compared to 8.36% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 90.28 111.27 -18.86 524.09 444.11 18.01 524.09 444.11 18.01
Other Income 0.83 0.65 27.69 8.48 4.14 104.83 8.48 4.14 104.83
PBIDT -9.45 8.36 -213.04 38.95 37.11 4.96 38.95 37.11 4.96
Interest 3.96 4.23 -6.38 16.75 15.89 5.41 16.75 15.89 5.41
PBDT -13.41 4.13 -424.70 22.20 21.22 4.62 22.20 21.22 4.62
Depreciation 4.72 10.92 -56.78 19.07 41.96 -54.55 19.07 41.96 -54.55
PBT -18.13 -6.79 167.01 3.13 -20.74 -115.09 3.13 -20.74 -115.09
TAX -2.10 0.69 -404.35 1.41 -4.57 -130.85 1.41 -4.57 -130.85
Deferred Tax -1.58 0.87 -281.61 1.08 -2.90 -137.24 1.08 -2.90 -137.24
PAT -16.03 -7.48 114.30 1.72 -16.17 -110.64 1.72 -16.17 -110.64
Equity 49.17 49.17 0.00 49.17 49.17 0.00 49.17 49.17 0.00
PBIDTM(%) -10.47 7.51 -239.32 7.43 8.36 -11.06 7.43 8.36 -11.06

Makers Laboratories Share Price

157.00 1.20 (0.77%)
15-Apr-2026 12:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.00
Dr. Reddys Lab 1217.60
Cipla 1224.60
Zydus Lifesciences 935.50
Lupin 2349.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×